Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Cancer Research|September 15, 1995
CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell lineC M Wendtner, B Schmitt, H J Gruss, et al.Cancer Research|April 15, 1992
Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alphaM A Brach, H J Gruss, Y Asano, et al.Cancer Research|August 1, 1993
Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene productS de Vos, M A Brach, Y Asano, et al.Leukemia & Lymphoma|June 28, 2001
Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: potential role of cytokines in clinical manifestationsI Al-Hashmi, J Decoteau, H J Gruss, et al.Blood|September 1, 1992
Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile proteinM A Brach, H J Bühring, H J Gruss, et al.Blood|October 1, 1994
Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's diseaseH J Gruss, D Hirschstein, B Wright, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene productY Asano, M A Brach, A Ahlers, et al.Diseases of the Colon and Rectum|October 24, 2002
Topical L-arginine gel lowers resting anal pressure: possible treatment for anal fissureN Griffin, D D E Zimmerman, J W Briel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
CD30 ligand in lymphoma patients with CD30+ tumorsA Younes, U Consoli, V Snell, et al.Cell|July 2, 1993
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNFC A Smith, H J Gruss, T Davis, et al.Pageof 7